Clinical Trial Update: A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer.

View source ↗

Summary

This trial compared XELOX (capecitabine + oxaliplatin) versus EOX (epirubicin + oxaliplatin + capecitabine) as neoadjuvant chemotherapy for locally advanced gas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Epirubicin (epirubicin)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Tianshu Liu | Conditions: Locally Advanced Gastric Cancer | Status: COMPLETED